Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127567601 | 12756760 | 1 | I | 20140914 | 20160909 | 20160917 | 20160917 | EXP | JP-AMGEN-JPNCT2016126413 | AMGEN | 78.00 | YR | E | M | Y | 60.00000 | KG | 20160917 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127567601 | 12756760 | 1 | PS | romiplostim | ROMIPLOSTIM | 1 | Subcutaneous | 1 MUG/KG, QD | 1 | UG/KG | D | 125268 | 1 | UG/KG | INVESTIGATIONAL DOSAGE FORM | QD | |||
| 127567601 | 12756760 | 2 | SS | romiplostim | ROMIPLOSTIM | 1 | Subcutaneous | 2 MUG/KG, QD | 1 | UG/KG | D | 125268 | 2 | UG/KG | INVESTIGATIONAL DOSAGE FORM | QD | |||
| 127567601 | 12756760 | 3 | SS | romiplostim | ROMIPLOSTIM | 1 | Subcutaneous | 3 MUG/KG, QWK | 1 | UG/KG | D | 125268 | 3 | UG/KG | INVESTIGATIONAL DOSAGE FORM | /wk | |||
| 127567601 | 12756760 | 4 | SS | ZOSYN | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | Intravenous (not otherwise specified) | UNK | 0 | INJECTION | |||||||||
| 127567601 | 12756760 | 5 | C | LANSAP | AMOXICILLINCLARITHROMYCINLANSOPRAZOLE | 1 | Oral | 800 MG, UNK | 0 | 800 | MG | ORAL DRUG UNSPECIFIED FORM | |||||||
| 127567601 | 12756760 | 6 | C | MAGMITT | MAGNESIUM OXIDE | 1 | Oral | UNK | 0 | ||||||||||
| 127567601 | 12756760 | 7 | C | MUCOSTA | REBAMIPIDE | 1 | Unknown | UNK | 0 | ||||||||||
| 127567601 | 12756760 | 8 | C | QUETIAPINE. | QUETIAPINE | 1 | Oral | UNK | 0 | ||||||||||
| 127567601 | 12756760 | 9 | C | ROHYPNOL | FLUNITRAZEPAM | 1 | Unknown | UNK | 0 | ||||||||||
| 127567601 | 12756760 | 10 | C | SEROQUEL | QUETIAPINE FUMARATE | 1 | Oral | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127567601 | 12756760 | 1 | Immune thrombocytopenic purpura |
| 127567601 | 12756760 | 4 | Product used for unknown indication |
| 127567601 | 12756760 | 5 | Immune thrombocytopenic purpura |
| 127567601 | 12756760 | 6 | Prophylaxis |
| 127567601 | 12756760 | 7 | Prophylaxis |
| 127567601 | 12756760 | 8 | Disuse syndrome |
| 127567601 | 12756760 | 9 | Disuse syndrome |
| 127567601 | 12756760 | 10 | Disuse syndrome |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127567601 | 12756760 | HO |
| 127567601 | 12756760 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127567601 | 12756760 | Haemorrhage | |
| 127567601 | 12756760 | Pseudomembranous colitis | |
| 127567601 | 12756760 | Pyrexia | |
| 127567601 | 12756760 | Rash |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127567601 | 12756760 | 1 | 20140829 | 20140829 | 0 | |
| 127567601 | 12756760 | 2 | 20140905 | 20140905 | 0 | |
| 127567601 | 12756760 | 3 | 20140919 | 20141003 | 0 | |
| 127567601 | 12756760 | 5 | 20140829 | 20140905 | 0 |